Georg Weinlich
YOU?
Author Swipe
View article: Dabrafenib plus trametinib in unselected advanced BRAF V600–mut melanoma: a non-interventional, multicenter, prospective trial
Dabrafenib plus trametinib in unselected advanced BRAF V600–mut melanoma: a non-interventional, multicenter, prospective trial Open
Objective The efficacy of combined BRAF and MEK inhibition for BRAF V600–mutant melanoma in a broad patient population, including subgroups excluded from phase 3 trials, remains unanswered. This noninterventional study (DATUM-NIS) assessed…
View article: Usage and benefit of the Internet as a source of information on disease and therapy in dermatology
Usage and benefit of the Internet as a source of information on disease and therapy in dermatology Open
Dear Editors, The presence and 24-hour availability of digital data on the internet have led to the fact that more and more people – including patients – obtain most of their medical and health information from the internet.1 However, it i…
View article: Verwendung und Nutzen des Internets als Informationsquelle für Erkrankungen und Therapien in der Dermatologie
Verwendung und Nutzen des Internets als Informationsquelle für Erkrankungen und Therapien in der Dermatologie Open
Sehr geehrte Herausgeber, die Präsenz digitaler Daten im Internet und ihre rund um die Uhr Verfügbarkeit haben dazu geführt, dass immer mehr Menschen – einschließlich Patienten – die meisten medizinischen und Gesundheitsinformationen aus d…
View article: SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria
SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria Open
Summary Background Cancer patients infected with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) have an increased risk of mortality. Here, we investigated predictive factors for coronavirus disease 2019 (COVID-19) associ…
View article: Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries Open
Background and objectives The incidence of melanoma is increasing. This places significant burden on societies to provide efficient cancer care. The European Cancer Organisation recently published the essential requirements for quality mel…
View article: Combining chemotherapy and autologous peptide‐pulsed dendritic cells provides survival benefit in stage IV melanoma patients
Combining chemotherapy and autologous peptide‐pulsed dendritic cells provides survival benefit in stage IV melanoma patients Open
Summary Background and Objectives We examined retrospectively whether the combination of standard dacarbazine (DTIC) and/or fotemustine chemotherapy and autologous peptide‐loaded dendritic cell (DC) vaccination may improve survival of stag…
View article: Kombination von Chemotherapie und autologen, Peptid‐beladenen dendritischen Zellen bringt Überlebensvorteil bei Melanompatienten im Stadium IV
Kombination von Chemotherapie und autologen, Peptid‐beladenen dendritischen Zellen bringt Überlebensvorteil bei Melanompatienten im Stadium IV Open
Zusammenfassung Hintergrund und Studienziele Wir untersuchten retrospektiv, ob die Kombination der Standardchemotherapie (Dacarbazin [DTIC] und/oder Fotemustin) und Vakzination mit autologen, Tumorpeptid‐beladenen dendritischen Zellen (DZ)…
View article: The Association of Residential Altitude on the Molecular Profile and Survival of Melanoma: Results of an Interreg Study
The Association of Residential Altitude on the Molecular Profile and Survival of Melanoma: Results of an Interreg Study Open
Cutaneous melanoma (CM) incidence is rising worldwide and is the primary cause of death from skin disease in the Western world. Personal risk factors linked to environmental ultraviolet radiation (UVR) are well-known etiological factors co…
View article: Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein Open
Immunotherapy for metastatic melanoma offers great promise but, to date, only a subset of patients have responded. There is an urgent need to identify ways of allocating patients to the most beneficial therapy, to increase survival and dec…
View article: More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments Open